Predictmedix (CSE: PMED-OTCQB: PMEDF) CEO Dr Rahul Kushwah joined Steve Darling from Proactive to bring news the company has filed a patent for their game-changing technology for mass screening for infectious disease such as COVID-19. Dr Kushwah discusses how the technology works and why he feels airports, stadiums and other large venues could be a perfect spot to use it.
Built on the QAI Platform – Enabling the next wave of quantum healthcare products.
